A rating of 90 puts GenMark Diagnostics, Inc (GNMK) near the top of the Medical Devices industry according to InvestorsObserver. GenMark Diagnostics, Inc's score of 90 means it scores higher than 90% of stocks in the industry. GenMark Diagnostics, Inc also received an overall rating of 64, putting it above 64% of all stocks. Medical Devices is ranked 45 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With GenMark Diagnostics, Inc Stock Today?
GenMark Diagnostics, Inc (GNMK) stock is trading at $18.45 as of 10:37 AM on Wednesday, Jul 8, a gain of $2.86, or 18.35% from the previous closing price of $15.59. The stock has traded between $16.90 and $18.48 so far today. Volume today is 2,322,695 compared to average volume of 2,039,125.
To see InvestorsObserver's Sentiment Score for GenMark Diagnostics, Inc click here.
